Germany vs Togo: Share of people with HIV who receive antiretroviral therapy
Germany
93.0%
in 2023
Togo
92.0%
in 2024
Germany rank
11th
Togo rank
14th
Share of people with HIV who receive antiretroviral therapy over time
- Germany
- Togo
How they compare
Germany currently reports 93.0% against 92.0% in Togo, a difference of 1.0%.
Across all 14 years both countries report, Germany has been ahead every year.
Germany ranks 11th and Togo ranks 14th of 143 countries.
Germany has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Germany | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 79.2% | 44.8% | 34.4% | Germany |
| 2020s | 92.0% | 82.0% | 10.0% | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Germany or Togo?
- Germany, at 93.0% against 92.0% in Togo as of 2023.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Germany and Togo?
- 1.0%, with Germany ahead.
- How many years of comparable data are there for Germany and Togo?
- 14 years are reported by both, from 2010 to 2023.
- How do Germany and Togo rank globally for share of people with hiv who receive antiretroviral therapy?
- Germany ranks 11th and Togo ranks 14th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.